Azenta Acquires Cold Chain Manufacturer
In deal to be finalized by October, purchases B Medical Systems for $423 million
Azenta, Inc., a provider of life sciences solutions, has entered into a definitive agreement to acquire B Medical Systems and its subsidiaries, a manufacturer and distributor of medical refrigeration and vaccine cold chain technology, for approximately $423 million in cash. Additional cash consideration of up to $52 million could be paid upon achievement of certain future performance milestones. The deal is expected to close in October 2022.
B Medical’s portfolio features vaccine transport systems with real-time monitoring solutions, medical refrigeration for ambient to -86°C temperatures, and blood management solutions. The acquisition—Azenta says—complements the company’s cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive samples.
"We are excited to add B Medical into our growing portfolio of offerings," comments Steve Schwartz, president and CEO of Azenta. "B Medical has done an outstanding job carving out a strong market position in the vaccine cold chain, and we see a breadth of opportunities to drive even further value from the portfolio by leveraging the Azenta platform."
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
